Real-World data shows how melanoma drugs perform outside clinical trials
NCT ID NCT04961619
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This study observed 39 patients in Turkey who had high-risk stage III melanoma removed by surgery and were then treated with dabrafenib and trametinib. Researchers tracked how long patients stayed cancer-free and how long they took the medication. The goal was to see how well these drugs work in everyday medical practice, not in a controlled trial setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Antalya, Konyaalti, 07070, Turkey (Türkiye)
-
Novartis Investigative Site
Edirne, Merkez, 22030, Turkey (Türkiye)
-
Novartis Investigative Site
Bursa, Nilufer, 16059, Turkey (Türkiye)
-
Novartis Investigative Site
Diyarbakır, Sur, 21280, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, Uskudar, 34668, Turkey (Türkiye)
-
Novartis Investigative Site
Adana, Yuregir, 1230, Turkey (Türkiye)
-
Novartis Investigative Site
Ankara, 06520, Turkey (Türkiye)
-
Novartis Investigative Site
Izmir, 35100, Turkey (Türkiye)
-
Novartis Investigative Site
Kecioren Ankara, 06010, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.